Microbot Medical (MBOT) Competitors $0.97 0.00 (-0.36%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends MBOT vs. APYX, MLSS, OM, APT, MODD, CTSO, NXL, NTRB, ICAD, and LUCDShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Apyx Medical (APYX), Milestone Scientific (MLSS), Outset Medical (OM), Alpha Pro Tech (APT), Modular Medical (MODD), Cytosorbents (CTSO), Nexalin Technology (NXL), Nutriband (NTRB), iCAD (ICAD), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Apyx Medical Milestone Scientific Outset Medical Alpha Pro Tech Modular Medical Cytosorbents Nexalin Technology Nutriband iCAD Lucid Diagnostics Microbot Medical (NASDAQ:MBOT) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings. Which has stronger valuation & earnings, MBOT or APYX? Microbot Medical has higher earnings, but lower revenue than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicrobot MedicalN/AN/A-$10.74M-$0.80-1.21Apyx Medical$48.54M1.22-$18.71M-$0.83-1.89 Do institutionals & insiders have more ownership in MBOT or APYX? 16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 10.5% of Microbot Medical shares are held by company insiders. Comparatively, 16.8% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts recommend MBOT or APYX? Microbot Medical currently has a consensus target price of $7.00, indicating a potential upside of 621.65%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Which has more volatility and risk, MBOT or APYX? Microbot Medical has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Does the media favor MBOT or APYX? In the previous week, Apyx Medical had 1 more articles in the media than Microbot Medical. MarketBeat recorded 1 mentions for Apyx Medical and 0 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 1.30 beat Apyx Medical's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media. Company Overall Sentiment Microbot Medical Positive Apyx Medical Neutral Does the MarketBeat Community believe in MBOT or APYX? Microbot Medical received 269 more outperform votes than Apyx Medical when rated by MarketBeat users. Likewise, 70.67% of users gave Microbot Medical an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformMicrobot MedicalOutperform Votes34770.67% Underperform Votes14429.33% Apyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Is MBOT or APYX more profitable? Microbot Medical has a net margin of 0.00% compared to Apyx Medical's net margin of -58.59%. Apyx Medical's return on equity of -137.98% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Microbot MedicalN/A -218.30% -158.17% Apyx Medical -58.59%-137.98%-36.74% SummaryMicrobot Medical beats Apyx Medical on 11 of the 18 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.42M$4.36B$5.10B$9.08BDividend YieldN/A41.46%4.88%4.21%P/E Ratio-1.2125.0190.8317.14Price / SalesN/A45.671,112.01116.85Price / CashN/A43.4642.0237.88Price / Book2.557.364.774.78Net Income-$10.74M$13.64M$119.70M$225.60M7 Day Performance-3.00%-2.82%-1.86%-1.23%1 Month Performance5.43%0.54%11.45%3.07%1 Year Performance-29.20%41.80%30.43%16.48% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical2.6641 of 5 stars$0.97-0.4%$7.00+621.6%-28.7%$16.42MN/A-1.2120APYXApyx Medical1.6647 of 5 stars$1.78+5.7%N/A-37.2%$66.82M$48.54M-2.23270Positive NewsMLSSMilestone Scientific1.4761 of 5 stars$0.84+3.7%$1.25+48.8%+54.0%$65.44M$8.88M-11.5730Analyst ForecastNews CoverageOMOutset Medical2.5559 of 5 stars$1.10-0.9%$4.50+309.1%-79.0%$57.79M$130.38M0.00520Positive NewsGap UpAPTAlpha Pro TechN/A$5.22-0.6%N/A+3.1%$57.42M$59.29M14.19120MODDModular Medical3.1834 of 5 stars$1.54-3.1%$5.00+224.7%-14.7%$53.42MN/A-2.5239News CoveragePositive NewsCTSOCytosorbents2.5619 of 5 stars$0.96-5.0%$2.00+108.3%-50.3%$52.49M$33.79M-2.81186Analyst ForecastPositive NewsGap DownNXLNexalin Technology1.3024 of 5 stars$3.90-1.5%$3.00-23.1%+806.9%$50.16M$162,078.00-6.193Gap DownNTRBNutriband0.4097 of 5 stars$4.39+6.0%N/A+63.2%$48.76M$2.02M-5.8310Positive NewsGap UpICADiCAD0.2943 of 5 stars$1.82-6.6%N/A+10.9%$48.33M$18.94M-15.0067LUCDLucid Diagnostics2.1501 of 5 stars$0.81+3.2%$3.63+347.3%-43.0%$48.10M$4.19M-0.6970News CoverageHigh Trading Volume Related Companies and Tools Related Companies Apyx Medical Alternatives Milestone Scientific Alternatives Outset Medical Alternatives Alpha Pro Tech Alternatives Modular Medical Alternatives Cytosorbents Alternatives Nexalin Technology Alternatives Nutriband Alternatives iCAD Alternatives Lucid Diagnostics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MBOT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
